Hopital Claude Huriez - Lille

Lille 59037

0 studies enrolling now · 1 studies all time

What they study most

Hepatocellular Carcinoma

Studies at this site

• Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors — Completed